Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) Motor Dysfunction Modeled in Mice

Area of Science:

• Neuroscience
• Genetics
• Neurology

Background:

• Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder affecting fragile X premutation (PM) carriers.
• FXTAS is characterized by CGG trinucleotide repeat expansion in the FMR1 gene, leading to altered FMR1 mRNA and FMRP expression.
• Key symptoms include ataxia, tremor, sensorimotor deficits, neuropsychiatric changes, and dementia.

Purpose of the Study:

• To review the current use of mouse models in studying fragile X premutation (PM) and FXTAS.
• To highlight recent advances in understanding the neurobiology of FXTAS pathogenesis.
• To discuss the validity, disease mechanisms, and potential therapeutic strategies derived from PM mouse models.

Main Methods:

• Review of existing literature on mouse models for fragile X premutation (PM) and FXTAS.
• Analysis of construct, face, and predictive validities of employed PM mouse models.
• Examination of insights gained into disease mechanisms and potential therapeutic targets.

Main Results:

• Mouse models provide valuable insights into the neurobiology underlying FXTAS.
• These models aid in understanding the progression from PM carrier status to FXTAS.
• Research using these models is advancing the identification of potential therapeutic interventions.

Conclusions:

• Mouse models are essential tools for investigating FXTAS pathogenesis and neurodegenerative pathways.
• Continued development and utilization of these models are critical for advancing therapeutic strategies.
• Further research using PM mouse models promises to elucidate mechanisms and guide treatment development for FXTAS.